University of Freiburg-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2021

  1. Survival and quality of life after early discharge in low-risk pulmonary embolism

    European Respiratory Journal, Vol. 57, Núm. 2

2017

  1. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study

    Thrombosis and Haemostasis, Vol. 117, Núm. 12, pp. 2425-2434

  2. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism

    Journal of the American College of Cardiology, Vol. 69, Núm. 12, pp. 1536-1544

2016

  1. Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: Rationale and design of the HoT-PE Trial

    Thrombosis and Haemostasis, Vol. 116, Núm. 1, pp. 191-197